How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Sterile Blood Collection Needle Market
- By Product Type: Hypodermic Needles, Butterfly Needles, Vacuum Blood Collection Needles, Safety Blood Collection Needles, Winged Infusion Sets
- By Gauge Size: 18G, 20G, 21G, 22G, 23G, 25G
- By Material: Stainless Steel, Plastic Coated Needles, Silicone Coated Needles
- By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Clinics, Ambulatory Surgical Centers
- By Sterilization Method: Ethylene Oxide (EO) Sterilization, Gamma Radiation Sterilization, Steam Sterilization (Autoclaving)
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Hypodermic Needles leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 296 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.181 →
- 12 Company Profiles 14 players: SWOT & benchmarking p.189 →
Full report · locked preview
Everything inside the Sterile Blood Collection Needle Market report
A complete, evidence-based study - 12 chapters and 124 sections covering market size, segmentation across 5 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Gauge Size 6
Material 3
End User 5
Sterilization Method 3
Companies profiled
Becton Dickinson and Company (BD)
Terumo Corporation
Smiths Medical
Nipro Corporation
B. Braun Melsungen AG
Fresenius Kabi
Nexcare (3M)
Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.
Hunan Kangjian Medical Instruments Co. Ltd.
Jiangxi Yuyue Medical Equipment & Supply Co. Ltd.
Ningbo David Medical Device Co. Ltd.
Medline Industries Inc.
+2 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Becton Dickinson and Company (BD)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Terumo Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Smiths Medical
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Nipro Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →B. Braun Melsungen AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Fresenius Kabi
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Nexcare (3M)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Hunan Kangjian Medical Instruments Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Jiangxi Yuyue Medical Equipment & Supply Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Ningbo David Medical Device Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Medline Industries Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Cardinal Health
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Vygon
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$904.0M by 2033 · 10.7% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Hypodermic Needles47.0
- Butterfly Needles10.3
- Vacuum Blood Collection Needles14.7
- Safety Blood Collection Needles14.5
- Winged Infusion Sets13.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$132.4M → $286.3M · 10.1%
Europe$92.3M → $225.9M · 11.8%
Asia Pacific$84.3M → $189.0M · 10.6%
Latin America$52.2M → $109.1M · 9.7%
Middle East and Africa$40.1M → $95.4M · 11.4%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.652026
10.642027
10.672028
10.682029
10.682030
10.712031
10.722032
10.732033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Becton Dickinson and Company (BD)23.0
- Terumo Corporation12.0
- Smiths Medical9.7
- Nipro Corporation8.9
- B. Braun Melsungen AG10.8
- Fresenius Kabi7.6
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type25.6%
Gauge Size19.9%
Material22.1%
End User13.7%
Sterilization Method18.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.6
- Europe24.9
- Asia Pacific20.9
- Latin America12.0
- Middle East and Africa10.5
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Becton Dickinson and Company (BD) | 77 | 98 | 93 | 89 | 75 | 92 | 87 |
| Terumo Corporation | 92 | 80 | 87 | 86 | 82 | 89 | 86 |
| Smiths Medical | 81 | 64 | 85 | 84 | 74 | 88 | 79 |
| Nipro Corporation | 78 | 62 | 78 | 70 | 71 | 60 | 70 |
| B. Braun Melsungen AG | 64 | 66 | 55 | 71 | 58 | 61 | 63 |
| Fresenius Kabi | 71 | 47 | 68 | 65 | 47 | 69 | 61 |
| Nexcare (3M) | 50 | 65 | 44 | 54 | 45 | 61 | 53 |
| Jiangsu Yuyue Medical Equipment & Supply Co. Ltd. | 48 | 57 | 57 | 51 | 46 | 51 | 52 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Becton Dickinson and Company (BD)
- Terumo Corporation
- Smiths Medical
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Becton Dickinson and Company (BD) | ◐ | ✓ | ✓ | ✓ | ◐ | ◐ |
| Terumo Corporation | ✓ | ✓ | ✓ | ✓ | ◐ | ◐ |
| Smiths Medical | ◐ | ◐ | ✓ | ✓ | − | ◐ |
| Nipro Corporation | ◐ | ◐ | ◐ | ◐ | − | ◐ |
| B. Braun Melsungen AG | ◐ | ◐ | − | ✓ | ◐ | ◐ |
| Fresenius Kabi | ◐ | − | ✓ | ◐ | − | ◐ |
| Nexcare (3M) | − | − | ◐ | ◐ | − | ◐ |
| Jiangsu Yuyue Medical Equipment & Supply Co. Ltd. | − | ◐ | ◐ | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Becton Dickinson and Company (BD)87
2Terumo Corporation86
3Smiths Medical79
4Nipro Corporation70
5B. Braun Melsungen AG63
6Fresenius Kabi61
7Nexcare (3M)53
8Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.52
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Becton Dickinson and Company (BD)Terumo CorporationSmiths Medical
Challenger1
Strong scale, closing on the leaders.
Nipro Corporation
Contender2
Focused players with pockets of strength.
B. Braun Melsungen AGFresenius Kabi
Niche2
Specialists in a single segment or region.
Nexcare (3M)Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Sterile Blood Collection Needle Market — a $516M beachhead inside a $7.82B market.
Beachhead (SOM)$516Mobtainable near-term
Serviceable (SAM)$3.07Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion86 fit
Hypodermic Needles
Best fit — highest urgency & budget in Product Type.
Economic buyer77 fit
Butterfly Needles
Strong fit — clear ROI and a fast path to value.
End user68 fit
Vacuum Blood Collection Needles
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Gauge Size & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Material
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel31%
Digital / self-serve17%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Sterile Blood Collection Needle Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified46%
Sales qualified22%
Evaluation15%
Closed-won8%
$18.9KCAC
$110KLTV
5.8:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Sterile Blood Collection Needle Market is a durable-growth opportunity — $1.54B by 2033, compounding at 7.9%.
TAM · 2025$838Mtoday
TAM · 2033$1.54Bforecast
CAGR7.9%2027–2033
Cumulative$10.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.54BTotal addressable market
SAM$609MServiceable available market
SOM$126MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.9% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.54BLarge & growingTAM by 2033 at 7.9% CAGR
$609MServiceable nowreachable with today’s model
$126MBeachhead winobtainable near-term share
14+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.20BBear5.1% CAGR
$1.54BBase7.9% CAGR
$1.97BBull10.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Gauge Size optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Sterile Blood Collection Needle Market — a $9.72B market by 2033. Plan: grow share from 8.1% to 15.6%.
Market size · 2033$9.72Btotal addressable
Market CAGR8.3%2027–2033
Target share15.6%from 8.1% today
Revenue ambition$1.52Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.1% | 15.6% | Ahead |
| Revenue | $752M | $1.52B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 28.2% | 39.9% | On track |
| Customer retention | 85.8% | 92.0% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Gauge Size capability
A defensible second engine — invest in Gauge Size to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Gauge Size
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $223M capacity & capability investment
- Greenlight bolt-on M&A in Gauge Size
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAt risk
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Sterile Blood Collection Needle Market conversation — a $5.36B market you can size, segment and defend in minutes.
Market size · 2033$5.36Btotal opportunity
Growth3.9%CAGR to 2033
Addressable buyers1,180+accounts in scope
Typical ROI6.6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.6×return on cost, year one
< 4 mopayback period
$60K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
14+players profiled in this market
Coverage includes
Becton Dickinson and Company (BD)Terumo CorporationSmiths MedicalNipro CorporationB. Braun Melsungen AGFresenius KabiNexcare (3M)Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.+6 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Sterile Blood Collection Needle Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Sterile Blood Collection Needle Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Sterile Blender Bag Market
Market size, share, segmentation and regional forecast.
$376M market · 2025 base year
View reportSterile Biological Wound Protection Film Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportSterile Biological Sample Bags Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportSterile Basic Surgical Pack Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportSterile Balloon Catheter Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportSterile Bacteria Filter Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportSterile Auto Disable Syringes Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportSterile Artificial Tears Market
Market size, share, segmentation and regional forecast.
$658M market · 2025 base year
View reportSterile Antimicrobial Gel Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportSterile and Non-Sterile Gloves Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportSterile Alcohol Swabs Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportSterile Alcohol Solutions Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.